Health Care & Life Sciences » Pharmaceuticals | Zhejiang Shapuaisi Pharmaceutical Co. Ltd.

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
104,082.00
131,269.90
176,036.30
275,717.40
146,356.40
126,474.30
Depreciation, Depletion & Amortization
12,525.00
24,877.10
27,527.20
42,507.10
50,081.60
52,693.90
Other Funds
10,847.00
306,742.00
-
380,808.10
-
173,703.40
Funds from Operations
121,879.00
155,331.30
206,679.40
319,450.30
242,623.60
99,303.20
Changes in Working Capital
4,018.00
13,620.50
89,267.90
30,916.10
197,051.40
1,070.30
Net Operating Cash Flow
117,861.00
141,710.80
117,411.60
288,534.30
45,572.20
100,373.50
Capital Expenditures
71,733.00
102,528.70
97,937.60
39,941.10
113,995.90
Sale of Fixed Assets & Businesses
23.00
1,099.40
12.50
709.40
16,031.00
Purchase/Sale of Investments
-
80,000.00
80,000.00
200,000.00
70,000.00
Net Investing Cash Flow
71,201.00
162,865.90
135,301.30
248,205.20
8,718.20
Cash Dividends Paid - Total
24,990.00
28,420.00
47,313.40
53,913.80
83,306.90
Issuance/Reduction of Debt, Net
3,100.00
180,000.00
50,000.00
50,000.00
-
Net Financing Cash Flow
32,737.00
98,322.00
2,686.60
276,894.40
83,306.90
Net Change in Cash
13,923.00
77,166.90
15,203.10
317,223.50
46,452.80
Free Cash Flow
46,128.00
39,182.20
19,473.90
248,593.10
68,423.70
Deferred Taxes & Investment Tax Credit
106.00
746.90
488.70
240.70
229.50
619.70
Net Assets from Acquisitions
-
-
134,523.70
-
-
Other Sources
509.00
18,563.30
17,147.50
80,526.60
19,246.70
Other Uses
-
-
-
89,500.00
-

About Zhejiang Shapuaisi Pharmaceutical Co.

View Profile
Address
No. 1588 Xinming Road
Pinghu Zhejiang 314200
China
Employees -
Website http://www.zjspas.com
Updated 07/08/2019
Zhejiang Shapuaisi Pharmaceutical Co., Ltd. engages in the manufacture and distribution of medicines and other pharmaceutical goods. Its products include Bendazac lysine drops, Cefixime tabelets, Mesylate pazufloxacin drop, normal saline solution, and compound sodium lactate and glucose injection. The company was founded in 1978 and is headquartered in Pinghu, China.